IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Effect of Diet-induced Weight Loss on HIV-associated Metabolic Syndrome
This study has been completed.
Sponsor:
Washington University School of Medicine
Information provided by (Responsible Party):
Washington University School of Medicine
ClinicalTrials.gov Identifier:
NCT00857298
First received: March 4, 2009
Last updated: February 13, 2015
Last verified: February 2015
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Obese HIV-positive women with Metabolic Syndrome (HIV-MS) and obese HIV-negative women with Metabolic Syndrome will be studied before and after achieving moderate (6%-8%) diet-induced weight loss. The investigators hypothesize that health markers will improve in both groups but that the improvement will be blunted in the women with HIV-MS.
| Condition | Intervention |
|---|---|
| HIV (Human Immunodeficiency Virus) Metabolic Syndrome HIV Infections | Behavioral: Dietary Intervention |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: None (Open Label) Primary Purpose: Basic Science |
| Official Title: | Effect of Diet-induced Weight Loss on HIV-associated Metabolic Syndrome |
Resource links provided by NLM:
Further study details as provided by Washington University School of Medicine:
Primary Outcome Measures:
- Effect of weight loss on body composition [ Time Frame: three months ]
- Effect of weight loss on insulin action [ Time Frame: three months ]
Secondary Outcome Measures:
- Effect of weight loss on body fat mass [ Time Frame: three months ]
- Effect of weight loss on adipose tissue distribution [ Time Frame: three months ]
- Effect of weight loss intrahepatic triglyceride content [ Time Frame: three months ]
- Effect of weight loss on insulin action adipose tissue [ Time Frame: three months ]
- Effect of weight loss on insulin action in liver [ Time Frame: three months ]
- Effect of weight loss on insulin action in skeletal muscle [ Time Frame: three months ]
| Enrollment: | 20 |
| Study Start Date: | February 2009 |
| Study Completion Date: | July 2014 |
| Primary Completion Date: | July 2014 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: HIV-MS
HIV-positive obese women with metabolic syndrome will be studied before and after losing 6-8% of body weight
|
Behavioral: Dietary Intervention
The nutrition curriculum will involve weekly group and individual sessions. The initial calorie goal will be ~750 kcal below the resting energy equivalent, and adjusted as needed to achieve weight loss targets.
|
|
Active Comparator: MS only
HIV-negative obese women with metabolic syndrome will be studied before and after losing 6-8% of body weight
|
Behavioral: Dietary Intervention
The nutrition curriculum will involve weekly group and individual sessions. The initial calorie goal will be ~750 kcal below the resting energy equivalent, and adjusted as needed to achieve weight loss targets.
|
Eligibility| Ages Eligible for Study: | 18 Years to 60 Years (Adult) |
| Sexes Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Sedentary
- Obese
- Have either dyslipidemia (HDL < 50 or triglycerides > 150), waist circumference > 88cm, and impaired glucose tolerance or homeostasis model assessment value of > 3
- Subjects with HIV-MS must have been receiving HAART for > 6 months
Exclusion Criteria:
- Medication changes in the last 3 months
- Diabetes mellitus
- Medical problems that in the opinion of the principal investigator may interfere with patient safety
- Substance abuse
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00857298
Please refer to this study by its ClinicalTrials.gov identifier: NCT00857298
Locations
| United States, Missouri | |
| Washington University School of Medicine | |
| Saint Louis, Missouri, United States, 63110 | |
Sponsors and Collaborators
Washington University School of Medicine
Investigators
| Principal Investigator: | Dominic Reeds, MD | Washington University School of Medicine |
More Information
| Responsible Party: | Washington University School of Medicine |
| ClinicalTrials.gov Identifier: | NCT00857298 History of Changes |
| Other Study ID Numbers: |
HW-08-0628 |
| Study First Received: | March 4, 2009 |
| Last Updated: | February 13, 2015 |
Keywords provided by Washington University School of Medicine:
|
HIV Metabolic Syndrome Obesity Treatment Experienced |
Additional relevant MeSH terms:
|
Syndrome HIV Infections Weight Loss Metabolic Syndrome X Immunologic Deficiency Syndromes Acquired Immunodeficiency Syndrome Disease Pathologic Processes Lentivirus Infections Retroviridae Infections RNA Virus Infections Virus Diseases |
Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immune System Diseases Body Weight Changes Body Weight Signs and Symptoms Insulin Resistance Hyperinsulinism Glucose Metabolism Disorders Metabolic Diseases Slow Virus Diseases |
ClinicalTrials.gov processed this record on September 21, 2017